Ameriprise’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.1M Buy
2,357,089
+255,633
+12% +$4.91M 0.01% 888
2026
Q1
$37M Buy
2,101,456
+173,540
+9% +$3.49M 0.01% 1032
2025
Q4
$38.1M Sell
1,927,916
-19,396
-1% -$348K 0.01% 1029
2025
Q3
$34M Buy
1,947,312
+880,056
+82% +$13M 0.01% 1095
2025
Q2
$14.9M Sell
1,067,256
-271,055
-20% -$4.36M ﹤0.01% 1526
2025
Q1
$24.9M Buy
1,338,311
+80,093
+6% +$1.19M 0.01% 1179
2024
Q4
$14.2M Buy
+1,258,218
New +$14.7M ﹤0.01% 1555

Other funds holding ALHC

Ameriprise's ALHC Position: Q2 2026 in Review

Ameriprise increased its Alignment Healthcare (ALHC) stake by 12% in Q2 2026, buying an estimated $4.91M and bringing the position to 2,357,089 shares worth $56.1M. The position accounts for 0.01% of the portfolio, ranked #888.

Ameriprise first reported a position in ALHC in Q4 2024 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Ameriprise held 2,357,089 shares of Alignment Healthcare worth $56.1M as of Q2 2026.
  • Ameriprise bought 255,633 Alignment Healthcare shares in Q2 2026, an estimated $4.91M.
  • Alignment Healthcare made up 0.01% of Ameriprise's portfolio in Q2 2026, its #888 holding.
  • Ameriprise first reported a position in Alignment Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.